Dr. David Latshaw, Ph.D. - Co-Founder and CEO, BioPhy - Providing Practical AI For Drug Development

Progress, Potential, and Possibilities

Ira Pastor द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Ira Pastor या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

4M ago 53:31

MP3•एपिसोड होम

Send us a text

Dr. David Latshaw, Ph.D. is Co-Founder and CEO of BioPhy ( https://www.biophy.ai/ ), a Philadelphia based artificial intelligence company which has developed a set of platforms that provide quantitative metrics to drug company partners about what drugs and clinical trials will ultimately succeed. Dr. Latshaw is a computational biomolecular and chemical engineer by training and most recently led the deployment of more than 20 programs that leveraged AI across several drug development functions at Johnson & Johnson’s Advanced Technologies Center of Excellence. This impacted $16 billion in yearly sales, reducing costs by 20 percent, and a 50 percent increase in reliability. His work has been recognized by the World Economic Forum, McKinsey & Company, and the National Academy of Engineering. Dr. Latshaw has a BSE in Chemical Engineering from Arizona State University, a Ph.D. in Chemical and Biomolecular Engineering from North Carolina State University, and a Master of Business Administration - MBA, Finance and Operations, from The Wharton School.

Support the show

551 एपिसोडस

#Science #Ira Pastor #Tech #Fitness #STEM #Technology #Research #Pharmaceutical #Biotechnology #Space #Neuroscience #Energy #Environment #National Security #Future